5 completed, 1 not yet recruiting. 3 Phase 4, 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 3 |
| Not applicable | 1 | Not yet recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow Edoxaban 60 mg: new trials by email Literature Review of Edoxaban 60 mg trials Research Report on Edoxaban 60 mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Edoxaban Steady-State PK/PD in Adults With Nephrotic Syndrome Edoxaban 60 mg, Enoxaparin 40 mg - Nephrotic Syndrome, Hypoalbuminemia | Not applicable | Not yet recruiting | Peking University People's Hospital | 60 | 2025-09-01 | 2025-08-11 |
| Prospective Comparison of Incidence of Heavy Menstrual Bleeding in Women Treated With Direct Oral Anticoagulants Apixaban 5 MG, Rivaroxaban 20 MG, Edoxaban 60 MG - Heavy Menstrual Bleeding | Completed | Cardioangiologisches Centrum Bethanien | 84 | 2020-10-15 | 2024-08-21 | |
| NOAC Plasma Concentration and Blood Coagulation in Healthy Volunteers Edoxaban 60 MG - Blood Coagulation Disorder | Phase 4 | Completed | Turku University Hospital | 15 | 2018-11-26 | 2019-09-17 |
| Lixiana Acute Stroke Evaluation Registry Edoxaban 60 MG, Edoxaban 30 mg - Ischemic Stroke, Atrial Fibrillation | Phase 4 | Completed | University of Alberta | 70 | 2018-06-01 | 2024-04-05 |
| A Healthy Volunteer PK/PD, Safety and Tolerability Study of Second Generation Andexanet Alfa Andexanet alfa (Gen 1 Process 2), Apixaban 5 MG, Rivaroxaban 20 MG - Bleeding | Phase 1 | Completed | Portola Pharmaceuticals | 153 | 2017-02-26 | 2023-08-08 |
| Edoxaban in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy With Aspirin and Clopidogrel Edoxaban 60 mg, Edoxaban 30 mg, Clopidogrel 75 mg - Coronary Artery Disease | Phase 4 | Completed | University of Florida | 80 | 2016-03-01 | 2018-04-06 |
Atrial Fibrillation (1) · Blood Coagulation Disorders (1) · Cerebral Hemorrhage (1) · Coronary Artery Disease (1) · Embolic Stroke (1) · Hemorrhage (1) · Hypoalbuminemia (1) · Ischemic Stroke (1) · Menorrhagia (1) · Nephrotic Syndrome (1)
Cardioangiologisches Centrum Bethanien (1) · Peking University People's Hospital (1) · Portola Pharmaceuticals (1) · Turku University Hospital (1) · University of Alberta (1) · University of Florida (1)
United States (2) · Canada (1) · Finland (1) · Germany (1)
Brian Buck, MD (1) · Dominick J Angiolillo, MD, PhD (1) · Edelgard Lindhoff-Last, Prof. (1) · Ken Butcher, MD (1)